In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3026-3031

  Krummenacher, Claude ^a   Diggelmann, Heidi ^a   Acha Orbea, Hans ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS EXPRESSION; VIRUS RECOMBINATION;

EID: 0029879038     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3026-3031.1996     Document Type: Article

References (49)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. Acha-Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Müller, A. Vessaz-Shaw, R. Fuchs, K. Blöchlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of V-beta14-bearing T cells in mice transgenic for mammary tumor virus. Nature (London) 350:207-211.
3. Acha-Orbea, H., R. M. Zinkernagel, and H. Hengartner. 1985. Cytotoxic T cell done-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur. J. Immunol. 15:31-36.
4. Alonso, J. M., J. Rodriguez, E. Vinuela, G. Kroemer, and C. Martinez-A. 1991 Highly efficient expression of proteins encoded by recombinant vaccinia virus in lymphocytes. Scand. J. Immunol. 34:619-626.
5. Andersson, M., and H. Acha-Orbea. 1994. The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern. Immunology 83:438-443.
6. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805-815.
7. Beutner, V., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457-1466.
8. Bittner, J. J. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice Science 84:162
9. Blöchlinger, K., and H. Diggelmann. 1992 Expression of the mouse mammary tumor virus ORF gene in cultured cells Intern. Rev. Immunol. 8:339-357.
10. Brandt-Carlson, C., and J. S. Butel. 1991 Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene. J. Virol. 65:6051-6060
11. Brandt-Carlson, C., J. S. Butel, and D. A. Wheeler. 1993. Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology 193:171-185.
12. Baller, R. M. L., G. L. Smith, K. Cremer, A. L. Notkins, and B. Moss. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (London) 317:813-815.
13. Choi, Y., J. W. Kappler, and P. Marrack. 1991 A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature (London) 350:203-207.
14. Choi, Y., P. Marrack, and J. W. Kappler. 1992. Structural analysis of a mouse mammary tumor virus superantigen. J. Exp. Med. 175:847-852
15. Corley, R. B., F. E. Lund, T. D. Randall, L. B. King, S. Doerre, and D. L. Woodland. 1992. Mouse mammary tumor proviral gene expression in cells of the B lineage. Semin. Immunol. Ser. 4:287-296
16. Dales, S., and B. G. T. Pogo. 1981 Biology of poxviruses. Virol. Monogr. 18:1-109.
17. D'Amiano, L., K. M. Awad, and E. L. Reinberz. 1993. Thrymic and peripheral apoptosis of antigen-specific T cells might cooperate in establishing self tolerance. Eur. J. Immunol. 23:747-753.
18. Eynon, E. E., and D. C. Parker. 1992 Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131-138.
19. Fenner, F., R. Wittek, and K. R. Dumbell. 1989. The orthupoxviruses. p. 1-432. Academic Press. Inc., San Diego, Calif.
20. Ferrick, D. A., K. Cho, L. Gemmell-Hori, and D. W. Morris. 1991. Genetic analysis of the effects of mtv-2 on the T cell repertoire in the WXG-2 mouse strain. Int. Immunol 4:805-810
21. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156-1159
22. Held, W., A. N. Shakhov, G. Waanders, I., Scarpellino, R. Luethy, J.-P. Kraehenbuhl, H. R. MacDonald, and H. Acha-Orbea, 1992. An exogenous mouse mammary tumor virus with properties of Mis-1a (Mtv7). J. Exp Med. 175:1623-1633.
23. Held, W., G. A. Waanders, H. Acha-Orbea, and H. R. MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J. Exp. Med 180:2347-2351.
24. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
25. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991 Superantigens mechanism of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
26. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor. N.Y.
27. Korman, A. J., P. Bourgarel, T. Meo, and G. E. Rieckhof. 1992. The mouse mammary tumor virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J. 11:1901-1905.
28. Koszinowski, U., F. Kruse, and R. Thomssen. 1975. Interactions between vaccinia virus and sensitized macrophages in vitro. Arch. Virol. 48:335-345.
29. Kozak, C., R. Callahan, G. Peters, V. Morris, R. Michalides, J. Dudley, M. Green, M. Davisson, O. Prakash, A. Vaidja, J. Hilgers, A. Verstraeten, N. Hynes, H. Diggelmann, D. Peterson, J. C. Cohen, C. Dickson, N. Sarkar, and R. Nusse. 1987. A standardized nomenclature for endogenous mouse mammary tumor viruses. J. Virol. 61:1651-1654.
30. Krummenacher, C. 1995. Ph.D. thesis. University of Lausanne. Lausanne, Switzerland
31. Krummenacher, C., and H. Diggelmann. 1993. The mouse mammary tumor virus long terminal repeat encodes a 47 kDa glycoprotein with a short half-life in mammalian cells. Mol. Immunol. 30:1151-1157.
32. Lambert, J.-F., H. Acha-Orbea, E. Kolb, and H. Diggelmann. 1993. The 3' half of the mouse mammary tumor virus orf gene is not sufficient for its superantigen function in transgenic mice. Mol. Immunol. 30:1399-1404.
33. + T cells. J. Immunol. 149: 1151-1155.
34. Lund, F. E., and R. B. Corley. 1991. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J Exp. Med. 174:1439-1450.
35. Luther, S., A. N. Shakhov, I. Xenarios, S. Haga, S. Imai, and H. Acha-Orbea. 1994. New infectious mammary tumor virus superantigen with Vbeta-specificity identical to staphylococcal enterotoxin B (SEB). Eur. J. Immunol. 24:1757-1764
36. Marrack, P., E. Kushnir, and J. Kappler. 1991. A maternally inherited superantigen encoded by a mammary tumor virus Nature (London) 349: 524-526.
37. Molina, I. J., N. A. Cannon, R. Hyman, and B.T. Huber. 1989 Macrophages and T cells do not express Mlsa determinants. J. Immunol. 143:39-44.
38. Moss, B. 1993. Poxvirus vectors: cytoplasmic expression of transferred genes. Curr. Opin. Genet. Dev. 3:86-90.
39. Natuk, R. J., and J. A. Holowczak. 1985 Vaccinia virus proteins on the plasma membrane of infected cells. Infection of peritoneal macrophages. Virology 147:354-372.
40. Nusse, R., and H. E. Varmus. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome Cell 31:99-109.
41. Rohrman, G., and B. Moss. 1985. Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions J Virol. 56:349-355.
42. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1979. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol 9:301-306.
43. Van Nie, R., A. A. Verstraeten, and J. De Moes. 1977. Genetic transmission of mammary tumour virus by GR mice. Int. J. Cancer 19:383-390.
44. Wahl, C., T. Miethke, K. Heeg, and H. Wagner. 1993. Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Eur. J Immunol. 23:1197-1200.
45. Webb, S. R., A. Okamoto, Y. Ron. and J. Sprent. 1989. Restricted tissue distribution of Misa determinants: stimulation of Mlsa-reactive T cells by B cells but not by dendritic cells or macrophages. J. Exp. Med. 169:1-12.
46. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vbeta-speafic superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35.
47. Winslow, G. M., P. Marrack, and J. W. Kappler. 1994. Processing and major histocompatibility complex binding of the mtv7 superantigen. Immunity 1:23-33.
48. Winslow, G. M., M. T. Scherer, J. W. Kappler, and P. Marrack. 1992. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a) Cell 71:719-730.
49. Yazdanbakhsh, K., C. G. Park, G. M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor Vbeta specificity J. Exp Med. 178:737-741.